LeCointe-Cephas Lisa
SEC CIK 1854644 · EDGAR
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| MRK | Merck & Co. | SVP Chief Ethics, Com Off | 5,142 | — | — | 10 | 2022-05-01 | 2023-05-03 |
Most active insiders at MRK, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Zachary Jennifer | EVP, GC | — | $25.20M |
| 2 | DeLuca Richard R. | EVP, Pres, Merck Animal Heallth | — | $11.29M |
| 3 | Guindo Chirfi | EVP, Access, Policy, Comms | — | $8.15M |
| 4 | Williams David Michael | EVP, Chief Info, Digital Off | — | $8.13M |
| 5 | Davis Robert M | COB, CEO, Pres, Dir | — | $5.60M |
| 6 | Litchfield Caroline | EVP, CFO | — | $5.02M |
| 7 | Li Dean Y | Pres, Executive VP, MRL | — | $2.99M |
| 8 | Maraldo David R. | EVP, Pres. MMD | — | $2.41M |
| 9 | Oosthuizen Johannes Jacobus | Pres, U.S. Market | — | $1.83M |
| 10 | Smart Dalton E. III | SVP Fin. - Gbl Ctrl | — | $766.0K |
LeCointe-Cephas Lisa made no open-market trades at MRK in the last 12 months.
Transactions 10
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2023-05-05 | 2023-05-03+ | MRK | Merck & Co. | LeCointe-Cephas Lisa | SVP Chief Ethics, Com Off | F - Tax | $118.07 | -515 | 5,142 | -9% | -$60.8K |
| DM | 2023-05-05 | 2023-05-03+ | MRK | Merck & Co. | LeCointe-Cephas Lisa | SVP Chief Ethics, Com Off | M - OptEx | $118.07 | +1,502 | 5,421 | +38% | +$177.3K |
| D | 2023-05-03 | 2023-05-01 | MRK | Merck & Co. | LeCointe-Cephas Lisa | SVP Chief Ethics, Com Off | M - OptEx | $115.47 | +643 | 4,376 | +17% | +$74.2K |
| D | 2023-05-03 | 2023-05-01 | MRK | Merck & Co. | LeCointe-Cephas Lisa | SVP Chief Ethics, Com Off | F - Tax | $115.47 | -221 | 4,155 | -5% | -$25.5K |
| D | 2022-05-05 | 2022-05-04 | MRK | Merck & Co. | LeCointe-Cephas Lisa | SVP Chief Ethics, Com Off | F - Tax | $87.10 | -279 | 3,664 | -7% | -$24.3K |
| D | 2022-05-05 | 2022-05-04 | MRK | Merck & Co. | LeCointe-Cephas Lisa | SVP Chief Ethics, Com Off | M - OptEx | $87.10 | +813 | 3,943 | +26% | +$70.8K |
| D | 2022-05-04 | 2022-05-03 | MRK | Merck & Co. | LeCointe-Cephas Lisa | SVP Chief Ethics, Com Off | F - Tax | $87.65 | -155 | 3,130 | -5% | -$13.6K |
| D | 2022-05-04 | 2022-05-03 | MRK | Merck & Co. | LeCointe-Cephas Lisa | SVP Chief Ethics, Com Off | M - OptEx | $87.65 | +452 | 3,285 | +16% | +$39.6K |
| D | 2022-05-03 | 2022-05-01 | MRK | Merck & Co. | LeCointe-Cephas Lisa | SVP Chief Ethics, Com Off | F - Tax | $88.69 | -220 | 2,833 | -7% | -$19.5K |
| D | 2022-05-03 | 2022-05-01 | MRK | Merck & Co. | LeCointe-Cephas Lisa | SVP Chief Ethics, Com Off | M - OptEx | $88.69 | +640 | 3,053 | +27% | +$56.8K |
Purchase Sale Sale after option exercise All abbreviations